Benedetta Bolognesi featured at “Maldita Ciencia” talking about coronavirus
IBEC in the Media
Benedetta Bolognesi, group leader at IBEC has been collaborating with “Maldita Ciencia” to clarify doubts and rumours about Covid-19″.A new method to find the best treatment for pediatric cancer
A study led by researchers from the Nanobioengineering Group at IBEC, in collaboration with other research centers and hospitals in Barcelona, uses a predictive biomarker to anticipate the success of drugs against rhabdomyosarcoma, which represents around 5 percent of childhood tumors . This advance can help in predicting treatment efficiency thus, avoiding tumor resistance and decreasing undesired secondary effects.
Where are STEM women in the pandemic?
International studies reveal that in the global health crisis women are doing less research, also in the coronavirus itself. Some of the reasons are the inequality in the housework distribution and the leadership distribution.
International studies reveal that in the global health crisis women are doing less research, also in the coronavirus itself. Some of the reasons are the inequality in the housework distribution and the leadership distribution.SPECS Lab featured on TV and Radio for its work on COVID19 and mental health
Researchers from the SPECS lab at IBEC have develop a new method to evaluate the mental health and wellbeing of people living under strict confinement measures such those during COVID-19 pandemic on April 2020. The study, conducted with people living in 17 countries, confirms that confinement measurements leads to a negative impact on the emotional wellbeing. The researchers also detected some personal situations that can entail a higher risk for the mental health and wellbeing.
Pere Roca-Cusachs elected new EMBO member
Pere Roca-Cusachs, principal investigator at IBEC, is the only Catalan chosen this year to join the prestigious European Molecular Biology Organization (EMBO).
Pere Roca-Cusachs, principal investigator at IBEC, is the only Catalan chosen this year to join the prestigious European Molecular Biology Organization (EMBO).Elisabeth Engel at Santander Pioneros: it’s time to support science
Three protagonists of the medical research field in Spain debated in a new edition of the “Pioneros Santander” forum, organized virtually by El País Retina. Elisabeth Engel, group leader of Biomaterials for regenerative therapies at IBEC, Rocío Arroyo, CEO of Amadix and Eduardo Jorgensen, of Medicsen, also CEO, agreed to celebrate the greatest interest in their work area, the intersection between science, technology and health, but at the same time they were cautious: there are no shortcuts in research, neither before Covid-19 nor after.
Three protagonists of the medical research field in Spain debated in a new edition of the “Pioneros Santander” forum, organized virtually by El País Retina. Elisabeth Engel, group leader of Biomaterials for regenerative therapies at IBEC, Rocío Arroyo, CEO of Amadix and Eduardo Jorgensen, of Medicsen, also CEO, agreed to celebrate the greatest interest in their work area, the intersection between science, technology and health, but at the same time they were cautious: there are no shortcuts in research, neither before Covid-19 nor after.Nuria Montserrat talks in the media about Mini-kidneys, diabetes and coronavirus
Researchers at the Institute of Bioengineering of Catalonia (IBEC) led by Núria Montserrat have found in vitro that diabetes is a disease that accelerates Covid-19. In the lab, they have also created mini-hearts to study the heart problems caused by Covid-19.
Researchers at the Institute of Bioengineering of Catalonia (IBEC) led by Núria Montserrat have found in vitro that diabetes is a disease that accelerates Covid-19. In the lab, they have also created mini-hearts to study the heart problems caused by Covid-19.A “faster and safer” therapy against tuberculosis
A team of international scientists led by the Institute for Bioengineering of Catalonia (IBEC) has developed a “faster, more effective and safer” therapy to eliminate infections of intracellular bacteria that cause diseases such as tuberculosis. Scientists participating in the study include Group Leader Giuseppe Battaglia and the researcher Loris Rizzello of IBEC.
Josep Samitier talks about how the redistribution of funds will affect research
Josep Samitier, director of the Institute for Bioengineering of Catalonia and president of the Catalan Association of Research Entities (ACER), assesses how science and technology can be affected by the fact that 53 million euros, that had to be invested in research, have been redirected to the healthcare sector, due to the coronavirus outbreak.
Samuel Sánchez elected new member of the Young Academy of Spain
An international committee has elected Samuel Sánchez, the European referent in nanomotors, as one of the new 13 researchers, among 185 candidates, who will be a member of the Young Academy of Spain.